A key molecular feature of EHE is the recurrent WWTR1-CAMTA1 gene fusion, which is present in approximately 90% of cases and is highly specific for EHE.[5,9] This fusion can assist in distinguishing EHE from other vascular tumors, especially in diagnostically ambiguous cases. This evidence concerns the gene CAMTA1 and vascular neoplasm.